Profile
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for improved solubility of APIs and extended-release. Validated as an eye drop, with successful pre-clinical studies in glaucoma, dry eye and uveitis, 20/20 OptimEyes is seeking partners to further develop these assets or those with novel or repurposed APIs targeting mucosal areas for co-development opportunities.
Website
Contact
-
Frances Lasowski, Chief Executive OfficerTel: +1 905-978-9262Email: frances@2020optimeyes.ca
-
-
-
-
-
Event details
Date: January 13 - 15, 2025
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
21 in total
-
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for…
-
AmacaThera is a venture-backed clinical stage biotechnology company supported by institutional investors… -
Custom Biologics is a regulatory compliant, large molecule bioanalytical… -
Esphera SynBio is developing next-generation cancer and immunoregulatory treatments through its innovative… -
Eurofins CDMO Alphora Inc. provides integrated solutions for small molecules, drug product,… -
For over two decades, Toronto area-based GL CHEMTEC has been dedicated to delivering innovative… -
HDAX Therapeutics is a biotechnology company pioneering a novel approach to targeting… -
ImmunoBiochem is an innovative, pharma-partnered biotech on a mission to develop novel bioconjugate therapeutics… -
Inteligex Inc. is a regenerative medicine company focused on improving clinical outcomes for patients with… -
Iseehear Inc. is a leading provider of comprehensive IT solutions for the biomedical research… -
Mannin Research Inc. is a Canadian private biotechnology company, headquartered in Toronto, Ontario. It is… -
Mediphage, a Toronto-based biotechnology company, has developed a proprietary and scalable manufacturing process… -
Plasmid DNA is starting material for cell and gene, RNA and DNA therapies… -
Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both… -
Oxford Cancer Analytics (OXcan) is creating a paradigm shift in early disease detection, monitoring… -
Pattern Pharma’s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting… -
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead… -
PurMinds NeuroPharma is a neuro-medicine development company pursuing breakthrough solutions for the treatment of… -
QurCan Therapeutics is developing tissue and cell-targeted genetic medicine using its proprietary hybrid polymer-… -
Spiderwort is a tissue engineering company that develops cellulose-based scaffolds for use in regenerative… -
TheraVac Biologics is developing novel vaccines and immunotherapies for aging-related diseases associated with…